Meshi A, Abu-Tawil H, Hamzi A, Madkhali B, Maghfori A, Alnami I
Int J Gen Med. 2024; 17:2855-2864.
PMID: 38947563
PMC: 11212813.
DOI: 10.2147/IJGM.S444949.
Weidner L, Allhoff W, Pistorius C, Witt V, Rohde E, Schistal E
Blood Transfus. 2022; 21(5):378-384.
PMID: 36346886
PMC: 10497382.
DOI: 10.2450/2022.0166-22.
Waldis S, Uter S, Kavitsky D, Flickinger C, Vege S, Friedman D
Blood Adv. 2021; 5(3):737-744.
PMID: 33560383
PMC: 7876880.
DOI: 10.1182/bloodadvances.2020003732.
Zheng Y, Chou S
Clin Lab Med. 2021; 41(1):101-119.
PMID: 33494879
PMC: 7842358.
DOI: 10.1016/j.cll.2020.10.007.
Macedo M, Miranda M, Santos T, Leal I, Castilho L
Blood Transfus. 2020; 19(5):413-419.
PMID: 33085591
PMC: 8486610.
DOI: 10.2450/2020.0073-20.
American Society of Hematology 2020 guidelines for sickle cell disease: transfusion support.
Chou S, Alsawas M, Fasano R, Field J, Hendrickson J, Howard J
Blood Adv. 2020; 4(2):327-355.
PMID: 31985807
PMC: 6988392.
DOI: 10.1182/bloodadvances.2019001143.
Red Cell Transfusions in the Genomics Era.
Carter J, Flegel W
Semin Hematol. 2019; 56(4):236-240.
PMID: 31836029
PMC: 7687018.
DOI: 10.1053/j.seminhematol.2019.11.001.
Transfusion Support in Patients with Hematologic Disease: New and Novel Transfusion Modalities.
Panch S, Savani B, Stroncek D
Semin Hematol. 2019; 56(4):227-228.
PMID: 31836027
PMC: 6917036.
DOI: 10.1053/j.seminhematol.2019.11.007.
Diversity of RH and transfusion support in Brazilian sickle cell disease patients with unexplained Rh antibodies.
Dinardo C, Kelly S, Dezan M, Ribeiro I, Castilho S, Schimidt L
Transfusion. 2019; 59(10):3228-3235.
PMID: 31408202
PMC: 6785370.
DOI: 10.1111/trf.15479.
Cross-Cultural Care Training for Pediatric Hematology/Oncology Fellows.
Rao A, Warad D, Rodriguez V
MedEdPORTAL. 2019; 13:10543.
PMID: 30800745
PMC: 6342230.
DOI: 10.15766/mep_2374-8265.10543.
Red Blood Cell Alloimmunization in Multitransfused Pediatric Population in a Tertiary Care Hospital.
Poornima A, Fazal S, Shaiji P, Usha K, Kailas L
Indian J Pediatr. 2018; 86(3):245-249.
PMID: 30515703
DOI: 10.1007/s12098-018-2815-9.
Clinical and epidemiological profile of alloimmunized and autoimmunized multi-transfused patients against red blood cell antigens in a blood center of Minas Gerais.
Valle Neto O, Alves V, de Araujo Pereira G, Moraes-Souza H, Martins P
Hematol Transfus Cell Ther. 2018; 40(2):107-111.
PMID: 30057983
PMC: 6001284.
DOI: 10.1016/j.htct.2017.08.001.
Transfusion in Haemoglobinopathies: Review and recommendations for local blood banks and transfusion services in Oman.
Al-Riyami A, Daar S
Sultan Qaboos Univ Med J. 2018; 18(1):e3-e12.
PMID: 29666675
PMC: 5892809.
DOI: 10.18295/squmj.2018.18.01.002.
Red blood cell minor antigen mismatches during chronic transfusion therapy for sickle cell anemia.
Yee M, Josephson C, Winkler A, Webb J, Luban N, Leong T
Transfusion. 2017; 57(11):2738-2746.
PMID: 28840600
PMC: 5673534.
DOI: 10.1111/trf.14282.
Application of genomics for transfusion therapy in sickle cell anemia.
Chou S, Westhoff C
Blood Cells Mol Dis. 2017; 67:148-154.
PMID: 28827079
PMC: 8966906.
DOI: 10.1016/j.bcmd.2017.08.006.
Genotyping Applications for Transplantation and Transfusion Management: The Emory Experience.
Fasano R, Sullivan H, Bray R, Gebel H, Meyer E, Winkler A
Arch Pathol Lab Med. 2017; 141(3):329-340.
PMID: 28234571
PMC: 5873318.
DOI: 10.5858/arpa.2016-0277-SA.
Economic evaluation of a hypothetical screening assay for alloimmunization risk among transfused patients with sickle cell disease.
Kacker S, Ness P, Savage W, Frick K, Shirey R, King K
Transfusion. 2014; 54(8):2034-44.
PMID: 24571485
PMC: 4138280.
DOI: 10.1111/trf.12585.
Cost-effectiveness of prospective red blood cell antigen matching to prevent alloimmunization among sickle cell patients.
Kacker S, Ness P, Savage W, Frick K, Shirey R, King K
Transfusion. 2013; 54(1):86-97.
PMID: 23692415
PMC: 3758770.
DOI: 10.1111/trf.12250.
Prevalence and specificities of red cell alloantibodies among blood recipients in the Malaysian state of Kelantan.
Al-Joudi F, Ali A, Ramli M, Ahmed S, Ismail M
Asian J Transfus Sci. 2011; 5(1):42-5.
PMID: 21572715
PMC: 3082716.
DOI: 10.4103/0973-6247.75997.
Duffy genotyping facilitates transfusion therapy.
Cotorruelo C, Biondi C, Racca L, Borras S, Racca A
Clin Exp Med. 2009; 9(3):249-51.
PMID: 19225719
DOI: 10.1007/s10238-009-0032-6.